Successful elimination of significant arrhythmia burden with flecainide in an adolescent with long QT syndrome type 3. [electronic resource]
- Congenital heart disease
- E42-5 p. digital
Publication Type: Case Reports; Journal Article
1747-0803
10.1111/j.1747-0803.2011.00596.x doi
Adolescent Anti-Arrhythmia Agents--therapeutic use Arrhythmias, Cardiac--drug therapy Flecainide--therapeutic use Humans Long QT Syndrome--classification Male Remission Induction